Spineology U.S. Fusion Trial Interim 12-Month Outcomes Data

Initial outcomes from Spineology's SCOUT trial of the OptiMesh® device revealed statistically significant improvements in low back pain and function scores at 6 and 12 months.

The Spineology Clinical Outcomes Trial, under an FDA-approved Investigational Device Exemption protocol, is a prospective multicenter non-randomized study of...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us